FDA warns Curaleaf to stop marketing CBD with unfounded claims - The Boston Globe

FDA warns Curaleaf to stop marketing CBD with unfounded claims - The Boston Globe: Federal regulators said that Curaleaf’s unfounded claims could endanger patients who might choose to delay seeking medical care.